Rustom Jilla
Analyst · Stifel. Your line is open
Thank you, Andreas.First, let me say how delighted I am to have joined IFF at this exciting time as we move past the integration of Frutarom to the combination with DuPont’s N&B business, and the many opportunities and challenges this will bring.For my part, I expect to focus on first, improving execution and accountability; second, enhancing effective collaboration across the business, that’s legacy IFF, Frutarom, and soon N&B; third, strengthening our cost discipline; and finally, delivering solid ROI.Now, on to the numbers. Reported sales increased by 29% in 2019 with three additional quarters of Frutarom being the major driver. Excluding Frutarom, currency-neutral sales grew 3% with 2019’s 53rd week contributing 1%. I’ll provide more color on sales by segment as we go through those slides.Our full year adjusted operating profit margin excluding amortization, rose by 30 basis points, driven by productivity initiatives, acquisition-related synergies and a Brazilian tax recovery. It’s also worth noting that in our fourth quarter, our currency-neutral EPS ex-amortization, grew a robust 23%, driven mostly by acquisition-related synergies, volume growth, lower incentive compensation, a Brazilian tax recovery, and a lower effective tax rate, which more than offset a headwind from higher raw material costs and mix.As the IFF team has done in previous quarters, I would like to highlight the impact of emerging market pricing on our growth rates to better compare to our peers. As a reminder, for a variety of reasons, many of our sales transactions in the emerging markets occur either in U.S. dollars or other hard currencies, or our index to hard currencies when we have to invoice in local market currencies. So, when reporting our currency-neutral sales growth, we exclude foreign exchange-related price changes in emerging markets. But, this is different from our peers. We believe that our reporting standard provides investors with a truer assessment of underlying currency-neutral growth, especially when there are large emerging market devaluations relative to the U.S. dollar or euro. However, it’s important to help all of you understand our performance relative to competition.For the fourth quarter of 2019, the stronger U.S. dollar environment plus emerging market devaluations year-over-year in several key markets had approximately a 1% currency impact on growth, if we include emerging market pricing. For the full year, this impact represented approximately a 2% currency impact on growth.Breaking it down a little further. Let’s move on to Scent, on slide 11. In the fourth quarter, currency-neutral sales increased year-over-year by 6% to $478.3 million. Fourth quarter performance was strongest in Consumer Fragrance, increasing in the high single digits from the prior year, driven by growth in Home, Fabric and Hair Care. Fine Fragrance grew in the mid single digits year-over-year, led by double-digit growth in both Greater Asia and in Latin America. At the same time, Fragrance Ingredients declined in the low single digits from last year as price increases were offset by volume declines, mainly as a result of industry destocking.For the full year, currency-neutral sales increased by 4% from 2018 to $1.9 billion with growth across all regions and in all categories, especially those that are a strategic focus. Both Fine Fragrance, with record new win contribution, and Consumer Fragrance grew in the mid single digits from 2018. Our performance in Fine Fragrance was driven by double-digit growth in EAME and Greater Asia, while as in the fourth quarter, Consumer Fragrance was led by strong improvements in Home and Fabric Care. For the year, Fragrance Ingredients improved by low double -- by low single digits, driven by price increases.For the full year, currency-neutral segment profit grew 6% and margin expanded 30 basis points to 17.3%. Drivers included raw materials-driven price increases as well as benefits from productivity initiatives that ran the gamut from manufacturing, procurement and make versus buy to innovation.Moving on to Taste on slide 12. In the fourth quarter, currency-neutral sales increased year-over-year by 8% to $429.9 million. This performance was led by double-digit growth in Greater Asia and high single digit growth in North America. Sales to multinationals, which had been under pressure in the last few quarters, grew mid single digits, indicating an inflection point in Q4. We also saw a much stronger growth from regional and local customers. From a category perspective, we were strongest in Beverage and Savory, helped greatly by strong new win performance.For the full year, currency-neutral sales increased by approximately 2% to $1.7 billion, driven by high single digit growth in Greater Asia and low single digit growth in EAME. As discussed during the year, we had some challenges in North America and Latin America related to volume declines with multinational customers. And as in the fourth quarter, full year 2019 growth was strongest in Beverage and Savory.For the full year, Taste posted an industry-leading 22.1% segment profit margin with $383 million in segment profit, which was supported by productivity increases, integration-related synergies and lower incentive compensation expense.Now, let’s move on to Frutarom’s performance on slide 13. In the fourth quarter, Frutarom currency-neutral sales increased year-over-year by 6%, including the net contribution of acquisitions and divested businesses, which is a sequential improvement in underlying performance. Organic currency-neutral growth for the quarter was 2%, essentially led by our Taste and Savory businesses.As discussed in past calls, Frutarom experienced compliance and portfolio-related transitory headwinds. Excluding these, organic currency-neutral growth would have been 6%. For the full year, sales were $1.5 billion for the segment, up 3% on a currency-neutral basis from the prior year, including the net contribution of acquisitions and divested businesses.In 2019, organic sales growth was flat. And if you exclude the transitory issues, organic currency-neutral sales growth was 3%, driven by solid growth in Taste and Savory solutions. The fastest-growing categories at Frutarom include double-digit increases in food protection, inclusions and algae.For the first for the full year, Frutarom’s segment profit was $127 million or $286 million, excluding amortization. And we finished the year with a strong quarterly segment profit increase of 24%, led by acquisition-related synergies. The full year operating margin excluding amortization was 19.2%, supported by delivering on our acquisition-related synergies and by disciplined cost management.Slide 14 provides some additional color on cash flow. As you will see, operating cash flow for the full year was up significantly from $438 million in 2018 to $699 million this year, a $261 million or 60% increase. This was driven primarily by higher cash earnings from Frutarom -- with Frutarom included for the entire year.Core working capital, defined as inventories, accounts receivables and accounts payables, improved year-over-year with progress in all three metrics. Inventories still remain at elevated levels, primarily due to raw material cost increases and safety stocks within the Scent division. However, in the fourth quarter, we saw continued positive trends.For 2019, CapEx as a percentage of sales was approximately 4.6%, which is a significant investment in the future. Throughout the year, we made new capital -- made new plant and capacity investments, mainly in Greater Asia as well as creative centers, and we invested in high-return integration-related synergy projects such as manufacturing optimization. Bringing all this together, we had strong $195 million increase in free cash flow for 2019, representing a 73% increase year-over-year.Moving on to slide 15. We expect full year 2020 sales of between $5.15 billion and $5.35 billion with adjusted EPS excluding amortization between $6.20 and $6.45.At this point in time, we expect a modest impact on sales from the recent coronavirus outbreak, but we are unable to quantify this as there are just too many variables and uncertainties. In addition, we have already incurred some relatively modest costs related to the outbreak as we acted to mitigate the impact on our supply chain. Right now, it’s too early to quantify the impact on our results, but we did widen both our sales and adjusted EPS ex-amortization guidance ranges to make some allowance for this as well as for continued volatile operating environment.The next slide provides some additional color about what we expect to drive our core sales growth for the year.Looking into our 2020 sales growth expectations and given the several moving parts, we felt it was important to give you an overview of the drivers. As you see from this slide, sales growth for 2020 is expected to be approximately 1% to 5% on a currency-neutral basis. This includes a headwind of about 0.5 percentage point impact from portfolio adjustments, namely the carryover impact from compliance and CitraSource, and an estimated 1 percentage point impact related to the 53rd week in the prior year period. Excluding these impacts, our core currency-neutral sales growth is expected to be approximately 2.5% to 6.5%, which includes approximately 2% to 5.5% from the organic business, 0.5% to 1% from cross-selling, and little to no impact from M&A.Now, let’s move to slide 17 for some additional color on what is driving our EPS growth. Adjusted EPS, excluding amortization growth for 2020 is expected to be approximately 3.5% to 7.5% on a currency-neutral basis. This includes a headwind of approximately 5 percentage points related to an incentive compensation reset, which is due to our performance versus our internal budget in 2019, an anticipated 0.5% impact due to our due to the portfolio adjustment, and an estimated 1 percentage point impact related to the 53rd week in the prior year. Excluding those impacts, core currency-neutral adjusted EPS ex-amortization is expected to grow in the range of 4% to 8%. We also expect to have a 6% positive contribution from integration synergies, which when added to our core growth, puts us in the double-digit growth range.Moving on to slide 18. I’m pleased to tell you that we remain on track to deliver on our commitment to delevering down to below 3 times net debt-to-EBITDA by the end of 2020 while maintaining an investment-grade rating. We are already down to approximately 3.2 times, down from 3.6 times a year ago, and we will continue to focus on improving working capital, tightly managing our CapEx while making the necessary investments and of course growing our cash earnings. To further support achieving this goal, management incentives are aligned to repayment of debt.With that, let me turn the call back to Andreas.